Michael Kiwanuka Discloses Severe Stroke, Pauses Touring as Completed Album Fudge Awaits Release

Michael Kiwanuka has suffered a stroke and faces a long, tough journey to recovery.

The 39-year-old singer from London disclosed the illness on September 23, 2026, in a personal statement posted to Instagram. He described the injury as severe and said rehabilitation will be prolonged The Guardian.

He said his stroke was brought on by a bleed in his brain, which was brought on by high blood pressure. High blood pressure strains blood vessels over time, which raises the risk of this kind of bleed. He said the brain injury he suffered was quite severe. He thanked NHS staff for caring for him. He said there is still a lot of rehab to be done.

He said he is unsure when he will return to touring. The disclosure explains his absence from tour dates this year, when he was due to support Mumford & Sons in the US. That absence had not previously been explained as a medical emergency. Reporting on the announcement places the stroke a few months before September, earlier in 2026.

His official website states there are currently no shows. The listing reflects an empty live schedule with no dates advertised official website.

Alongside the health update, Kiwanuka announced a new album titled Fudge that was recorded before his stroke. He published the announcement as A letter from Michael on Instagram on September 23, 2026. In that post he said more news on Fudge would come tomorrow Instagram.

The album was therefore completed before the interruption to his touring and public activity. No release date, tracklist or label detail was included in the verified facts. The announcement frames Fudge as a finished work awaiting rollout while its maker recovers.

His catalogue includes Cold Little Heart and Home Again. He released his debut album Home Again in 2012. He released his chart-topping record Love And Hate in 2016. He won the 2020 Mercury Prize.

The broader context here is the collision of a serious medical event with an album cycle. For a recording artist, a record made before illness but released after it creates distinct pressures, much like preparing an exhibition the artist cannot attend in person. Promotion, live performance and press are normally central to how a new album reaches listeners. Those avenues depend on health, stamina and travel. Kiwanuka has put touring on indefinite hold.

Looking at what this means for listeners and for his team, the timeline will be set by rehabilitation rather than by a release calendar. A bleed in the brain linked to high blood pressure can require months of monitored recovery, and Kiwanuka himself has emphasized uncertainty about a return to the stage. The decision to announce Fudge now suggests a desire to keep creative work visible while acknowledging that live work cannot proceed. It also gives his audience a clear explanation for silence.

In my view, the statement is notable for its directness. He names the cause as he understands it, describes the severity without minimizing it, and credits the clinicians who treated him. He does not set expectations for recovery. That candour leaves room for a prolonged absence while preserving a connection through recorded music made before the stroke.